Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Inc. Regulatory News (DIG)

Share Price Information for Dunedin Inc. (DIG)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.331%)
Market Cap: £356.03m
DIG Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Inc. Share Chart

Board Changes

31 Jan 2025 10:43

RNS Number : 4807V
Dunedin Income Growth Inv Tst PLC
31 January 2025
 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier (LEI): 549300PPXLZPR5JTL763

 

 

 

31 January 2025

 

 

Board Changes

The Board of Dunedin Income Growth Investment Trust PLC (the "Company") is pleased to announce the appointment of Arun Kumar Sarwal as an independent non-executive Director of the Company with effect from 1 February 2025. 

 

Arun Kumar Sarwal is a Chartered Accountant and has broad experience of global equities and fund management over some 35 years in the UK, Europe, and Asia. He is a Board Advisor to Tumelo and a director and Chairman of the Audit Committee of JPMorgan European Discovery Trust plc. His previous roles include CEO of Broadridge Fund Communication Solutions, Senior Vice President of SS&C Technologies, COO and CFO at Scottish Widows Investment Partnership and global roles at ABN AMRO and Societe Generale Investment Bank.

 

Arun will stand for election at the Annual General Meeting to be held in May 2025. There are no other disclosures required under Section 6.4.8 of the FCA's Listing Rules in relation to this appointment.

 

As previously stated, Jasper Judd and David Barron, who both joined the Board in February 2016 will retire as Directors at the conclusion of the Company's Annual General Meeting in May. It is the Board's intention that Arun Kumar Sarwal will be appointed as Chairman of the Audit Committee in place of Jasper Judd at that time. As previously stated, Howard Williams, who has been a Director since April 2018, will succeed David Barron as Chair of the Company following the AGM.

 

It is the Board's intention to recruit a further Director in 2025 to bring the number of Directors back to five.

 

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKDBQKBKDBDN
Date   Source Headline
4th Jun 20263:01 pmRNSMonth End Net Asset Value(s)
4th Jun 202611:57 amRNSNet Asset Value(s)
3rd Jun 202611:25 amRNSNet Asset Value(s)
2nd Jun 202612:19 pmRNSNet Asset Value(s)
1st Jun 20263:44 pmRNSGearing Disclosures
1st Jun 20269:21 amRNSTotal Voting Rights
29th May 202611:43 amRNSNet Asset Value(s)
28th May 202611:53 amRNSNet Asset Value(s)
27th May 202611:48 amRNSNet Asset Value(s)
26th May 20262:45 pmRNSGearing Disclosures
26th May 202612:19 pmRNSNet Asset Value(s)
22nd May 202612:09 pmRNSNet Asset Value(s)
21st May 20263:16 pmRNSResult of AGM
21st May 202611:30 amRNSNet Asset Value(s)
20th May 202612:16 pmRNSNet Asset Value(s)
19th May 202611:37 amRNSNet Asset Value(s)
18th May 20264:41 pmRNSGearing disclosure
18th May 202612:15 pmRNSNet Asset Value(s)
15th May 202612:29 pmRNSNet Asset Value(s)
14th May 202610:53 amRNSNet Asset Value(s)
13th May 202611:19 amRNSNet Asset Value(s)
13th May 20269:09 amRNSPortfolio disclosure
12th May 202612:35 pmRNSNet Asset Value(s)
11th May 202612:33 pmRNSGearing disclosure
11th May 202611:31 amRNSNet Asset Value(s)
8th May 202611:55 amRNSNet Asset Value(s)
7th May 20262:00 pmRNSMonth End Net Asset Value(s)
7th May 202610:46 amRNSNet Asset Value(s)
6th May 20265:05 pmRNSTransaction in Own Shares
6th May 202611:57 amRNSNet Asset Value(s)
5th May 20265:14 pmRNSTransaction in Own Shares
5th May 20264:40 pmRNSQuarterly disclosure
5th May 20262:05 pmRNSGearing disclosure
5th May 202610:44 amRNSNet Asset Value(s)
1st May 20269:52 amRNSTotal Voting Rights
30th Apr 20265:06 pmRNSTransaction in Own Shares
30th Apr 202611:32 amRNSNet Asset Value(s)
29th Apr 20265:05 pmRNSTransaction in Own Shares
29th Apr 202611:09 amRNSNet Asset Value(s)
28th Apr 20265:15 pmRNSTransaction in Own Shares
28th Apr 202611:25 amRNSNet Asset Value(s)
27th Apr 20265:05 pmRNSTransaction in Own Shares
27th Apr 20263:09 pmRNSGearing disclosure
27th Apr 202611:52 amRNSNet Asset Value(s)
24th Apr 20265:08 pmRNSTransaction in Own Shares
24th Apr 202611:25 amRNSNet Asset Value(s)
23rd Apr 20265:05 pmRNSTransaction in Own Shares
23rd Apr 202612:18 pmRNSDoc re. Annual Report
23rd Apr 202610:50 amRNSNet Asset Value(s)
22nd Apr 20265:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.